130 related articles for article (PubMed ID: 12006530)
1. Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors.
Agarwal R; Strickland S; McNeish IA; Patel DC; Foskett M; Boultbee JE; Newlands ES; Seckl MJ
Clin Cancer Res; 2002 May; 8(5):1142-7. PubMed ID: 12006530
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia.
Agarwal R; Harding V; Short D; Fisher RA; Sebire NJ; Harvey R; Patel D; Savage PM; Lim AK; Seckl MJ
Br J Cancer; 2012 Mar; 106(6):1089-94. PubMed ID: 22374461
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5-6.
Sita-Lumsden A; Medani H; Fisher R; Harvey R; Short D; Sebire N; Savage P; Lim A; Seckl MJ; Agarwal R
BJOG; 2013 Jul; 120(8):1012-5. PubMed ID: 23759086
[TBL] [Abstract][Full Text] [Related]
4. Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study.
Harvey RA; Elias KM; Lim A; Bercow A; Short D; Horowitz NS; Berkowitz RS; Agarwal R; Seckl MJ
Curr Probl Cancer; 2021 Feb; 45(1):100622. PubMed ID: 32800689
[TBL] [Abstract][Full Text] [Related]
5. Vascular patterns of gestational trophoblastic tumors by color Doppler ultrasound.
Hsieh FJ; Wu CC; Lee CN; Chen TM; Chen CA; Chen FC; Chen CL; Hsieh CY
Cancer; 1994 Oct; 74(8):2361-5. PubMed ID: 7522951
[TBL] [Abstract][Full Text] [Related]
6. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
7. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
8. [Trophoblastic pregnancy persistant disease with a menopausal woman: ultrasonography-Doppler benefits].
Benabu-Saada L; Roussel E; Body G; Marret H
Gynecol Obstet Fertil; 2008 Apr; 36(4):403-6. PubMed ID: 18420442
[TBL] [Abstract][Full Text] [Related]
9. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
10. Transvaginal color Doppler studies in gestational trophoblastic disease.
Kawano M; Masuzaki H; Ishimaru T
Ultrasound Obstet Gynecol; 1996 Mar; 7(3):197-200. PubMed ID: 8705413
[TBL] [Abstract][Full Text] [Related]
11. The role of Doppler sonography in assessment of malignant trophoblastic disease.
Chan FY; Pun TC; Chau MT; Lam C; Ngan HY; Wong RL
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):123-8. PubMed ID: 8886694
[TBL] [Abstract][Full Text] [Related]
12. Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy.
Long MG; Boultbee JE; Langley R; Newlands ES; Begent RH; Bagshawe KD
Br J Cancer; 1992 Nov; 66(5):883-7. PubMed ID: 1329910
[TBL] [Abstract][Full Text] [Related]
13. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
14. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
15. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Kizaki S; Hashimoto K; Matsui H; Usui H; Shozu M
Gynecol Oncol; 2015 Dec; 139(3):429-32. PubMed ID: 26456138
[TBL] [Abstract][Full Text] [Related]
18. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
[TBL] [Abstract][Full Text] [Related]
19. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
[TBL] [Abstract][Full Text] [Related]
20. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
